Post by
ForRealNowAndNo on Aug 16, 2016 11:03am
General Partner walk in...$15 / $18 ...$25???
What would a GP be willing to pay to get in? And how much CXR needs to raise? If they plan to go international, they absolutely need a GP. While encouraging, this dilutes the stock further and it will take longer to built value. I think this is what Thompson's after. He must negotiate and get the OK from his creditors though.
Comment by
derekli on Aug 16, 2016 11:07am
a good point, seems selling drug to other Africa Asian middle east, Can solve problem of the drug competition (their most competition from USA).this can create a huge profit
Comment by
Juice004 on Aug 16, 2016 11:11am
For the amount of risk they are taking probably closer to book value which is still lower from these levels
Comment by
ForRealNowAndNo on Aug 16, 2016 11:16am
Pharma's one if not the biggest lobby. Financiers play now along the political lines, but in the end healthcare will make money.